Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell" - Easy ... and will be available at pharmacy and drugstores throughout Japan. Chocola BB Nightwell contains eight active ...

The proclamation says Tren de Aragua "is a hybrid criminal state that is perpetrating an invasion of and predatory incursion into the United States," and so any person 14 years or older who is a Tren ...

Wall Street is having another tough day amid anxiety over President Donald Trump’s often-changing tariff proposals ...

Sidus Space (the "Company" or "Sidus"), an innovative, agile space mission enabler, today announced the signing of a Memorandum of Understanding (MOU) with Warpspace, a pioneering Japanese space-tech ...

We believe that if successful, this last set of clinical trials to complete will be pivotal to form the basis for our new drug application ... last month, the Japanese Patent Office granted ...

Trump pauses tariffs on most imports from Mexico as Trudeau expects Canada-U.S. trade war to continue: Live updates - Delay in import taxes for one month builds to promised roll out of reciprocal ...

Trump pauses tariffs on both Mexico and Canada until April after calls with Sheinbaum and Trudeau: Live - President clarifies responsibility for mass firings and cost-cutting lies with department lead ...

Rhythm Pharmaceuticals received an orphan-drug designation from Japan's Ministry of Health, Labour and Welfare for its treatment for a certain type of obesity.

Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...